Biogen Inc (BIIB)
193.70
-0.53
(-0.27%)
USD |
NASDAQ |
Apr 23, 12:10
Biogen Free Cash Flow: 1.236B for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.236B |
| September 30, 2023 | 1.026B |
| June 30, 2023 | 1.123B |
| March 31, 2023 | 1.421B |
| December 31, 2022 | 1.141B |
| September 30, 2022 | 2.173B |
| June 30, 2022 | 2.315B |
| March 31, 2022 | 2.772B |
| December 31, 2021 | 3.345B |
| September 30, 2021 | 2.107B |
| June 30, 2021 | 2.461B |
| March 31, 2021 | 3.149B |
| December 31, 2020 | 3.678B |
| September 30, 2020 | 5.841B |
| June 30, 2020 | 6.349B |
| March 31, 2020 | 6.282B |
| December 31, 2019 | 6.409B |
| September 30, 2019 | 6.384B |
| June 30, 2019 | 6.324B |
| March 31, 2019 | 5.382B |
| December 31, 2018 | 5.302B |
| September 30, 2018 | 4.855B |
| June 30, 2018 | 4.659B |
| March 31, 2018 | 4.671B |
| December 31, 2017 | 2.588B |
| Date | Value |
|---|---|
| September 30, 2017 | 2.764B |
| June 30, 2017 | 2.126B |
| March 31, 2017 | 2.169B |
| December 31, 2016 | 3.860B |
| September 30, 2016 | 3.509B |
| June 30, 2016 | 3.459B |
| March 31, 2016 | 3.486B |
| December 31, 2015 | 3.261B |
| September 30, 2015 | 3.010B |
| June 30, 2015 | 3.202B |
| March 31, 2015 | 3.211B |
| December 31, 2014 | 2.626B |
| September 30, 2014 | 2.619B |
| June 30, 2014 | 2.359B |
| March 31, 2014 | -1.259B |
| December 31, 2013 | -1.164B |
| September 30, 2013 | -1.515B |
| June 30, 2013 | -1.623B |
| March 31, 2013 | 1.631B |
| December 31, 2012 | 1.625B |
| September 30, 2012 | 1.590B |
| June 30, 2012 | 1.625B |
| March 31, 2012 | 1.438B |
| December 31, 2011 | 1.520B |
| September 30, 2011 | 1.498B |
Free Cash Flow Range, Past 5 Years
1.026B
Minimum
Sep 2023
6.409B
Maximum
Dec 2019
3.449B
Average
2.772B
Median
Mar 2022
Free Cash Flow Benchmarks
| Eli Lilly and Co | -3.152B |
| Bristol-Myers Squibb Co | 12.65B |
| Gilead Sciences Inc | 7.421B |
| AbbVie Inc | 22.06B |
| Regeneron Pharmaceuticals Inc | 3.668B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 12.50M |
| Cash from Investing (Quarterly) | -652.30M |
| Cash from Financing (Quarterly) | -646.10M |
| Free Cash Flow Per Share (Quarterly) | -0.3612 |
| Free Cash Flow to Equity (Quarterly) | 295.50M |
| Free Cash Flow to Firm (Quarterly) | -11.98M |
| Free Cash Flow Yield | 4.39% |